Forte Biosciences, Inc.
FBRX
$17.00
$1.338.49%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 58.22M | 76.96M | 93.41M | 106.14M | 45.86M |
| Total Receivables | 655.00K | 817.00K | 527.00K | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.99M | 2.39M | 1.00M | 884.00K | 853.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 242.00K | 422.00K | 471.00K | 588.00K | 449.00K |
| Total Current Assets | 65.11M | 80.59M | 95.41M | 107.62M | 47.16M |
|
|
|||||
| Total Current Assets | 65.11M | 80.59M | 95.41M | 107.62M | 47.16M |
| Net Property, Plant & Equipment | 110.00K | 129.00K | 148.00K | 110.00K | 125.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.00M | 2.06M | 1.53M | 57.00K | 176.00K |
| Total Assets | 67.22M | 82.78M | 97.09M | 107.78M | 47.46M |
|
|
|||||
| Total Accounts Payable | 13.08M | 9.99M | 5.49M | 5.30M | 5.02M |
| Total Accrued Expenses | 9.64M | 9.84M | 7.50M | 3.87M | 4.01M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 927.00K | 927.00K | -- | -- | -- |
| Total Other Current Liabilities | 927.00K | 927.00K | -- | -- | -- |
| Total Current Liabilities | 23.65M | 20.75M | 12.99M | 9.17M | 9.03M |
|
|
|||||
| Total Current Liabilities | 23.65M | 20.75M | 12.99M | 9.17M | 9.03M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.48M | 1.04M | -- | -- | -- |
| Total Liabilities | 25.12M | 21.79M | 12.99M | 9.17M | 9.03M |
|
|
|||||
| Common Stock & APIC | 287.61M | 284.36M | 282.69M | 279.52M | 208.08M |
| Retained Earnings | -245.51M | -223.37M | -198.59M | -180.90M | -169.65M |
| Treasury Stock & Other | -4.00K | 3.00K | -6.00K | -- | -- |
| Total Common Equity | 42.10M | 60.99M | 84.10M | 98.61M | 38.43M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 42.10M | 60.99M | 84.10M | 98.61M | 38.43M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 42.10M | 60.99M | 84.10M | 98.61M | 38.43M |
|
|
|||||